Title : EGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenib.

Pub. Date : 2012 Dec 15

PMID : 22514082






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A combination of EGFR inhibitors and sorafenib affords a better control over HCC proliferation, most likely through an improved blockade of the RAF kinases. Sorafenib zinc fingers and homeoboxes 2 Homo sapiens